Validation of an NGS mutation detection panel for melanoma

被引:0
|
作者
Anne Reiman
Hugh Kikuchi
Daniela Scocchia
Peter Smith
Yee Wah Tsang
David Snead
Ian A Cree
机构
[1] University Hospitals Coventry and Warwickshire,Department of Pathology – Coventry and Warwickshire Pathology Services (CWPS)
[2] Coventry University,Centre for Research in Applied Biological and Exercise Sciences
[3] University College London,Institute of Ophthalmology
[4] Coventry University,Centre for Technology Enabled Health Research (CTEHR), Faculty of Health & Life Sciences
来源
BMC Cancer | / 17卷
关键词
Melanoma; NGS; PCR; Mutation; BRAF; NRAS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Know Your NGS Assay: The Need for Augmentation of NGS Panel Performance Characteristics for Detection of Variants in Hematological Malignancies
    Thomas, M.
    Zhang, T.
    Dolatshahi, R.
    Sukhai, M. A.
    Garg, S.
    Misyura, M.
    Pugh, T.
    Stockley, T. L.
    Kamel-Reid, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1040 - 1040
  • [42] Development and Validation of an NGS-Based MSI Detection Method
    Xiao, S.
    Wang, T.
    Chen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1201 - S1202
  • [43] Clinical validation of NAVIFY® Mutation Profiler for solid tumor NGS variant interpretation
    Scudder, Sidney Alexander
    Grewal, Anoop
    Capucion, Lisha
    Zhang, Guili
    Formin, Leonid
    Krishna, Shuba
    Decker, Xi
    Chung, Joanie
    CANCER RESEARCH, 2020, 80 (16)
  • [44] Validation and Utility of HIV Drug Resistance Mutation (DRM) Analysis by NGS Platform
    Kolhe, R.
    Ananth, S.
    Jones, K.
    Heneidi, S.
    Mondal, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1152 - 1153
  • [45] Validation of a MEK/MET-specific NGS panel for early phase trial interrogation
    Maxwell, Perry
    Del Favero, Jurgen
    Fuchs, Marc-Aurel
    Tabernero, Josep
    Maughan, Tim
    Middleton, Mark
    Addams, Richard
    Rolfo, Christian
    Hennessey, Brian
    Laurent-Puig, Pierre
    Bardelli, Alberto
    Andre, Thierry
    Popovici, Vlad
    Johnstone, Patrick
    Wilson, Richard
    Lawler, Mark
    Van Schaeybroeck, Sandra
    Tellez, Manuel Salto
    CANCER RESEARCH, 2016, 76
  • [46] Validation of a Lab Developed 32-Gene All Exon NGS Myeloid Panel
    Shen, S.
    Lal, J.
    Zheng, Z.
    Gandhi, S.
    Moscinski, L.
    de Mola, C. Loret
    Qin, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 810 - 810
  • [47] Validation and utilization of NGS based HEMEaccuTest panel and analysis software for hematological malignancies.
    Choi, Hyun-Jeung
    Lee, In-seon
    Lee, Min Kyoung
    Im, Ji-Eun
    Jung, Kyongyong
    Lee, Keunsook Kathy
    Moon, YoungJoon
    Kim, Kwanq Joong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Validation of Ion Torrent™ Inherited Disease Panel with the PGM™ Sequencing Platform for Rapid and Comprehensive Mutation Detection
    Mustafa, Abeer E.
    Faquih, Tariq
    Baz, Batoul
    Kattan, Rana
    Al-Issa, Abdulelah
    Tahir, Asma I.
    Imtiaz, Faiqa
    Ramzan, Khushnooda
    Al-Sayed, Moeenaldeen
    Alowain, Mohammed
    Al-Hassnan, Zuhair
    Al-Zaidan, Hamad
    Abouelhoda, Mohamed
    Al-Mubarak, Bashayer R.
    Al Tassan, Nada A.
    GENES, 2018, 9 (05)
  • [49] MET amplification and activating mutation analysis in solid tumors using comprehensive NGS panel.
    Ai, Xinghao
    Yuan, Mingming
    Zhao, Jun
    Miao, Liyun
    Lin, Gen
    Du, Xueming
    Wu, Jun
    Zhang, Longbo
    Cheng, Xiangyang
    Xu, Chunwei
    Wang, Wen-xian
    Chen, Rongrong
    Xia, Xuefeng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Validation Strategy for Ultrasensitive Mutation Detection
    Marija Debeljak
    Michael Noë
    Stacy L. Riel
    Lisa M. Haley
    Alexis L. Norris
    Derek A. Anderson
    Emily M. Adams
    Masaya Suenaga
    Katie F. Beierl
    Ming-Tseh Lin
    Michael G. Goggins
    Christopher D. Gocke
    James R. Eshleman
    Molecular Diagnosis & Therapy, 2018, 22 : 603 - 611